Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Miraç Barış Usta

Datos Biográficos

ID7657846
NOMBREMiraç Barış Usta
NOMBRESMiraç Barış
APELLIDOUsta
FIRMAUSTÁ M B
AFILIACIONESAmerican Academy of Child and Adolescent Psychiatry
ORCID0000-0002-1573-3165
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2025
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0
  • Preliminary efficacy of pharmacological treatments on sluggish cognitive tempo (cognitive disengagement syndrome)

    Open Access•Şenay Kılınçel, Furkan Bulut et al.•ARTICLE•Frontiers in Psychiatry•2026

    Preliminary evidence suggests that pharmacological treatments, particularly atomoxetine and methylphenidate, may be associated with moderate improvements in SCT/CDS symptoms. However, given the limited number of controlled trials and the heterogeneity in populations (e.g., ADHD with comorbid dyslexia), these findings should be considered exploratory. Further large-scale RCTs are necessary to confirm these results and establish personalized treatm…

  • From promise to practice

    Open Access•Armağan Aral, Gizem Gerdan et al.•ARTICLE•Frontiers in Psychiatry•2025

    Mental health professionals show cautious optimism toward ChatGPT-4o, with discipline-specific emphases. While a measured interest in ChatGPT-4o's clinical integration, shared concerns around ethics highlight the need for role-specific guidelines and human oversight

Sin obras prominentes en esta página.

  • From promise to practice

    Open Access•Armağan Aral, Gizem Gerdan et al.•ARTICLE•Frontiers in Psychiatry•2025

    Mental health professionals show cautious optimism toward ChatGPT-4o, with discipline-specific emphases. While a measured interest in ChatGPT-4o's clinical integration, shared concerns around ethics highlight the need for role-specific guidelines and human oversight

  • Preliminary efficacy of pharmacological treatments on sluggish cognitive tempo (cognitive disengagement syndrome)

    Open Access•Şenay Kılınçel, Furkan Bulut et al.•ARTICLE•Frontiers in Psychiatry•2026

    Preliminary evidence suggests that pharmacological treatments, particularly atomoxetine and methylphenidate, may be associated with moderate improvements in SCT/CDS symptoms. However, given the limited number of controlled trials and the heterogeneity in populations (e.g., ADHD with comorbid dyslexia), these findings should be considered exploratory. Further large-scale RCTs are necessary to confirm these results and establish personalized treatm…

Adolescent and Pediatric Healthcare (1 obras) · Artificial Intelligence in Healthcare and Education (1 obras) · Atomoxetine (1 obras) · Attention Deficit Hyperactivity Disorder (1 obras) · Cognition (1 obras) · Digital Mental Health Interventions (1 obras) · Disengagement theory (1 obras) · Ethical issues (1 obras) · Health professionals (1 obras) · MEDLINE (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae